High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae171 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Thilo Gambichler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ruhr-University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Skin Neoplasms, 5-Methylcytosine, Neoplasm Recurrence, Local. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Hydroxymethylation plays a significant role in cancer development and progression. We hypothesized that hydroxymethylation markers may have prognostic potential in AFX/PDS (atypical fibroxanthoma/pleomorphic dermal sarcoma) as also observed in other tumours. Moreover, we wanted to find out whether hydroxymethylation markers might aid differentiation between AFX and PDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
- Department of Dermatology, Christian Hospital Unna, Unna, Germany.
- Department of Dermatology, Dortmund Hospital gGmbH and Faculty of Health, University of Witten-Herdecke, Dortmund, Germany.
- Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, Dermatology, University Duisburg-Essen, Essen, Germany.
- German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Thilo Gambichler
Zitieren
APA
Gambichler, T., Razeghpour, F., Sorescu, E., Stücker, M., Abu Rached, N., Becker, J. C., & Susok, L. (2024). High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae171
Vancouver
Gambichler T, Razeghpour F, Sorescu E, Stücker M, Abu Rached N, Becker JC, et al. High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae171
BibTeX
@article{Gambichler2024,
author = {Gambichler, Thilo and Razeghpour, Fahimeh and Sorescu, Emilia and Stücker, Markus and Abu Rached, Nessr and Becker, Jürgen C and Susok, Laura},
title = {High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae171}
}
EUVIMED